The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans-Reference-Cited by-同舟云学术

The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans

Published:2006-04 Issue:4 Volume:122 Page:494-510
ISSN:0168-1656
Container-title:Journal of Biotechnology
language:en
Short-container-title:Journal of Biotechnology

Author:

Puri Satish Chandra,Nazir Asiya,Chawla Raman,Arora Rajesh,Riyaz-ul-Hasan S.,Amna Touseef,Ahmed Bilal,Verma Vijeshwar,Singh Shikha,Sagar Ravinder,Sharma Ashok,Kumar Raj,Sharma Rakesh Kumar,Qazi Ghulam Nabi

Publisher

Elsevier BV

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology,Bioengineering

Reference57 articles.

1. Decolorization and detoxification of textile dyes with a laccase from Trametes hirsuta;Abadulla;Appl. Environ. Microbiol.,2000

2. Gapped BLAST and PSI-BLAST, 1997. A new generation of protein database search programs;Altschul;Nucl. Acids Res.,1997

3. Are tropical fungal endophytes hyperdiverse?;Arnold;Ecol. Lett.,2000

4. Radioprotection by plant products: present status and future prospects;Arora;Phytotherp. Res.,2005

5. Evaluation of radioprotective activities of Rhodiola imbrricata Edgew—a high altitude plant;Arora;Mol. Cell. Biochem.,2005

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer and antimicrobial potential of forest endophytes;Forest Fungi;2025

2. Genomic characterization and identification of candidate genes for putative podophyllotoxin biosynthesis pathway in Penicillium herqueiHGN12.1C;Microbial Biotechnology;2024-09

3. Solid Lipid Nanoparticles for the Delivery of Plant-derived Bioactive Compounds in the Treatment of Cancer Disorders – A Review;Journal of Natural Remedies;2024-07-31

4. Microbial allies: exploring fungal endophytes for biosynthesis of terpenoid indole alkaloids;Archives of Microbiology;2024-07-03

5. Endophytic fungi: A future prospect for breast cancer therapeutics and drug development;Heliyon;2024-07